Home > Boards > US Listed > Biotechs > Adamis Pharmaceuticals Corporation (ADMP)

I'm checking the 1 minute chart to see

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
ShortsRClowns Member Profile
 
Followed By 13
Posts 1,808
Boards Moderated 1
Alias Born 06/04/20
160x600 placeholder
Adamis Announces Agreement to Sell Portion of US Compounding Business GlobeNewswire Inc. - 8/4/2021 4:05:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/19/2021 4:07:09 PM
Adamis Announces Results of 2021 Annual Meeting of Stockholders Business Wire - 7/19/2021 4:05:00 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 7/13/2021 8:28:19 AM
Adamis Urges Stockholders to Vote to Reelect the Company’s Board of Directors at Upcoming Annual Meeting on Friday, July 16th Business Wire - 7/13/2021 8:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 7/13/2021 6:04:57 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/13/2021 6:04:07 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 7/1/2021 8:21:18 AM
 Adamis Sends Letter to Stockholders to Address Jerald A. Hammann’s Costly, Distracting and Misguided Campaign Business Wire - 7/1/2021 8:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/28/2021 7:32:31 AM
Adamis Sends Letter to Stockholders Regarding Its Strategic Focus on Tempol as a Potentially Potent Treatment for COVID-19 Business Wire - 6/28/2021 7:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/14/2021 10:32:44 AM
Adamis Files Definitive Proxy Statement and Sends Letter to Stockholders Business Wire - 6/14/2021 9:00:00 AM
Proxy Statment - Contested Solicitations (definitive) (defc14a) Edgar (US Regulatory) - 6/14/2021 6:03:38 AM
Adamis begins clinical trial start-up activities for COVID drug; shares rise 5% Seeking Alpha - 6/11/2021 8:33:04 AM
Adamis Provides Update on Clinical Trial Start-Up Progress for Tempol in the Treatment of COVID-19 GlobeNewswire Inc. - 6/11/2021 7:30:00 AM
Adamis Pharma soars 18% after FDA accepts Zimhi application for review Seeking Alpha - 6/9/2021 7:46:12 AM
Adamis Provides Update on ZIMHI™ GlobeNewswire Inc. - 6/9/2021 7:30:00 AM
Adamis Highlights National Institute of Health Study Identifying Tempol as a Potential Antiviral Drug for COVID-19 GlobeNewswire Inc. - 6/7/2021 7:30:00 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 6/2/2021 5:37:32 PM
Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) Edgar (US Regulatory) - 6/2/2021 8:20:43 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/1/2021 4:37:06 PM
Adamis Pharmaceuticals Provides Business Update GlobeNewswire Inc. - 6/1/2021 7:30:00 AM
Adamis pharmaceuticals gets deficiency letter from NASDAQ Seeking Alpha - 5/28/2021 4:09:47 PM
Adamis Pharmaceuticals Announces Receipt of Deficiency Letter from NASDAQ GlobeNewswire Inc. - 5/28/2021 4:04:00 PM
ShortsRClowns   Wednesday, 05/05/21 10:23:17 AM
Re: None
Post # of 3058 
I'm checking the 1 minute chart to see if it indicated this massive drop was coming following yesterdays pop. Stay tuned.

.25 isn't a lot of money and 7's aren't lucky. Ignore the noise!
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences